Colonial Trust Advisors’s Novo Nordisk NVO Stock Holding History

Colonial Trust Advisors’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$172K	Sell	3,581 -486	-12%	-$20.9K	0.01%	217
2026 Q1	$149K	Sell	4,067 -699	-15%	-$33.1K	0.01%	226
2025 Q4	$243K	Sell	4,766 -456	-9%	-$23.3K	0.02%	189
2025 Q3	$290K	Buy	5,222 +1,935	+59%	+$113K	0.02%	178
2025 Q2	$227K	Sell	3,287 -228	-6%	-$15.5K	0.02%	191
2025 Q1	$244K	Buy	3,515 +2,965	+539%	+$245K	0.02%	187
2024 Q4	$47.3K	Hold	550	–	–	﹤0.01%	315
2024 Q3	$65.5K	Hold	550	–	–	0.01%	304
2024 Q2	$78.5K	Buy	550 +4	+0.7%	+$530	0.01%	273
2024 Q1	$70.1K	Buy	546 +96	+21%	+$11.4K	0.01%	283
2023 Q4	$46.6K	Hold	450	–	–	﹤0.01%	324
2023 Q3	$40.9K	Hold	450	–	–	﹤0.01%	346
2023 Q2	$36.4K	Hold	450	–	–	﹤0.01%	369
2023 Q1	$35.8K	Hold	450	–	–	﹤0.01%	370
2022 Q4	$30.5K	Buy	+450	New	+$26.4K	﹤0.01%	387

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Colonial Trust Advisors's NVO Position: Q2 2026 in Review

Colonial Trust Advisors reduced its Novo Nordisk (NVO) stake by 12% in Q2 2026, selling an estimated $20.9K and leaving 3,581 shares worth $172K. The position accounts for 0.01% of the portfolio, ranked #217.

Colonial Trust Advisors first reported a position in NVO in Q4 2022 and has held it in 15 quarters since. The position peaked at $290K in Q3 2025. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Colonial Trust Advisors held 3,581 shares of Novo Nordisk worth $172K as of Q2 2026.
Colonial Trust Advisors sold 486 Novo Nordisk shares in Q2 2026, an estimated $20.9K.
Novo Nordisk made up 0.01% of Colonial Trust Advisors's portfolio in Q2 2026, its #217 holding.
Colonial Trust Advisors first reported a position in Novo Nordisk in Q4 2022 and has held it in 15 quarters since.
Colonial Trust Advisors's Novo Nordisk position peaked at $290K in Q3 2025.
1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Colonial Trust Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.